CURRICULUM VITAE

Stephen E. DePasquale, MD

Date of Birth: June 11, 1965

Place of Birth: Troy, New York

EDUCATION:

Undergraduate Albany College of Pharmacy

Education: Albany, New York

Degree: Bachelor of Science – Pharmacy

August 1983 – May 1988

Date of Degree: June 1988

Medical School: St. George’s University School of Medicine

St. George’s, Grenada

August 1988 – July 1991

University of Medicine and Dentistry of New Jersey

Robert Wood Johnson Medical School at Camden

Degree: Medical Doctorate

August 1991 – June 1993

Date of Degree: June 1993

Internship: Internship in Obstetrics and Gynecology,

University of Pennsylvania

Pennsylvania Hospital, Philadelphia, Pennsylvania

July 1, 1993 to June 30, 1994

Residency: Obstetrics and Gynecology

University of Pennsylvania

Pennsylvania Hospital, Philadelphia, Pennsylvania

July 1, 1994 to June 30, 1997

Fellowship: Gynecologic Oncology

Women’s & Infants Hospital

Brown University, Program in Women’s Oncology

Providence, Rhode Island

July 1, 1997 to June 30, 2001

HONORS/AWARDS:

Galloway Fellow in Gynecologic Oncology, Memorial Sloan-Kettering Cancer Center 1996

John M. Riva Excellence in Gynecologic Oncology 1997

The OB/GYN Administrator Award, Pennsylvania Hospital 1997

Award for Excellence North Eastern Cancer Society

Activin Levels in Recurrent Epithelial Ovarian Cancer 1998

Outstanding Fellow Award, from Chief Residents Dept.

OB/GYN, Women & Infants Hospital, Brown University

Medical School 2001

Outstanding Teaching Award, Dept. OB/GYN

University of Tennessee COM, Chattanooga 2003

Association of Professor of Gynecology and Obstetrics (APGO)

Award for excellence in teaching 2006

BOARD CERTIFICATION:

National Board of Medical Examiners July 1994 #40153306

American Board of Obstetrics & Gynecology

Obstetrics and Gynecology Board Certified January 2003

Gynecologic Oncology Board Certified April 2006

American College of Surgeons

Board Certified April 2004

LICENSURE:

Active Medical Licensure:

Tennessee 35113 Exp. 06/30/15

Georgia 0501542001 Exp. 12/31/15

DEA: BD5666788 Exp. 06/30/22

Inactive Medical Licensure:

Pennsylvania 057349-L

Rhode Island 09509

Massachusetts 1564551998

New Jersey 68161

Connecticut 037449

New Jersey (Registered Pharmacist) RI – 22376

New York (Registered Pharmacist) 038889

SOCIETY/PROFESSIONAL MEMBERSHIPS:

American Medical Association 1991

Chattanooga Regional Oncology Association 2001

Chattanooga Hamilton County Medical Society 2001

Tennessee Medical Association 2001

American College of Obstetrics and Gynecology, Fellow 2003

American College of Surgeons, Fellow 2004

Society of Gynecologic Oncology, Full Member 2006

UNIVERSITY APPOINTMENTS:

Clinical Instructor, Gynecologic Oncology

Women & Infants Hospital, Providence, Rhode Island

July 1997 to 2001

Clinical Instructor & Research Investigator

University of Rhode Island, S. Kingstown, Rhode Island

July 1997 to 2001

Research Fellow, Department of Obstetrics and Gynecology

Brown University, Providence, Rhode Island

June 1998 to 2001

Assistant Professor, Department of Obstetrics and Gynecology

University of Tennessee College of Medicine, Chattanooga

July 1, 2001 – 2009

Associate Professor, Department of Obstetrics and Gynecology

University of Tennessee College of Medicine, Chattanooga

2009 - Present

HOSPITAL/CLINICAL APPOINTMENTS:

Women & Infants Hospital

Providence, Rhode Island Active July 1997 – June 2001

Chattanooga, Tennessee

Erlanger Health System Active July 2001 – Present

Parkridge Medical Center Active July 2001 – Present

Parkridge Medical Center

Medical Director of Robotic Surgery July 2006 – Present

Memorial Hospital Active July 2001 – Present

Hutcheson Medical Center

Fort Oglethorpe, Georgia Active July 2001 – Present

PRACTICE/PROFESSIONAL EXPERIENCE:

Pennsylvania Hospital, Philadelphia, Pennsylvania July 1993 – June 1997

Women & Infants Hospital, Providence, Rhode Island July 1997 – June 2001

Chattanooga GYN Oncology, Chattanooga, Tennessee 2001 – 2006

Chattanooga’s Program in Women’s Oncology

102 Central Avenue Chattanooga, Tennessee 2006 – Present

37403 Phone 423-266-3636 Fax 423-266-3633

e-mail

TEACHING EXPERIENCE:

Proctor/Instructor for Intuitive Robotic Surgery

05/06 University of Tennessee College of Medicine, Chattanooga, Tennessee

07/06 Wake Forest University, Winston-Salem, North Carolina

08/06 Yale Medical Center, New Haven, Connecticut

09/06 Abington Memorial Hospital, Philadelphia, Pennsylvania

10/06 Abington Memorial Hospital, Philadelphia, Pennsylvania

04/08 Galveston Texas

2009-2011 University of Tennessee College of Medicine, Chattanooga, Tennessee

VISITING PROFESSORSHIPS AND INVITED LECTURES:

1.  DePasquale SE, McGuinness T, Husson M, Mangan C. Adenoid Cystic Carcinoma of Bartholin’s Gland, Case Report and Review of the Literature. Presented at The First Annual Meeting of the Thomas Bond Society, Philadelphia, PA. May 1994.

2.  DePasquale SE, Lambert-Messerlian GM, Maybruck WM, Steinhoff MM, Gajewski WH. Investigating Potential Tumor Markers in Epithelial Ovarian Cancer. Annual Meeting of the North Eastern Cancer Society 1998.

3.  DePasquale SE, Lambert-Messerlian GM, Maybruck WM, Steinhoff MM, Gajewski WH. Activin A Levels in recurrent Epithelial Ovarian Cancer. Annual Meeting of New England Association of Gynecologic Oncologists 1998.

4.  Ellison MC, DePasquale SE, Granai CO, Falkenberry SS, Gajewski WH, Stellar MA, Legare RD, Sung J, Quddus M, Cofone J and Lauchlan SC. Indolent Behavior of Mesonephric Adenocarcinoma of Cervix. Annual Meeting of New England Association of Gynecologic Oncologists 1998.

5.  DePasquale SE, Lambert-Messerlian GM, Maybruck WM, Steinhoff MM, Gajewski WH. Preoperative Evaluation of Serum Activin Levels in Patients with Ovarian Pathology: Benign Versus Malignant Disease. Annual Meeting of New England Association of Gynecologic Oncologists 1999.

6.  DePasquale SE, Lambert-Messerlian GM, Quddus M, Campbell I, Steinhoff MM, Gajewski WH, Tantravahi U. Molecular Analysis of Activin A and Inhibin A Subunit Gene Loci in Epithelial Ovarian Cancer. Annual Meeting of New England Association of Gynecologic Oncologists 2000.

7.  DePasquale SE, Ellison MC, Complementing Care and Alternative Medicine: The Fellow’s Perspective. The Society of Gynecologic Oncologists 2000.

8.  DePasquale SE, Lambert-Messerlian G, Steinhoff M, Quddus M, Gajewski W and Tantravahi U. Molecular Analysis of Activin A and Inhibin in Epithelial Ovarian Cancer (EOC). National Gynecologic Oncology Fellows Forum, San Diego, California 2000.

9.  Moore R, DePasquale SE, Steinhoff MM, Gajewski W, Steller M, Falkenberry S. Sentinel Node Identification and the Ability to Detect Metastatic tumor to Inguinal Lymph Nodes in Vulvar Malignancies. Annual Meeting of New England Association of Gynecologic Oncologists 2001.

10.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. Breast Disease January 29, 2001.

11.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. CREOG Review December 12, 2001.

12.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. Ovarian Cancer January 30, 2002.

13.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. Chemotherapy for Gynecologic Oncology Patients August 23, 2002.

14.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. Evaluation of Abdominal Pelvic Mass October 30, 2002.

15.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. Cervical Cancer February 4, 2003.

16.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, Department of Obstetrics and Gynecology Lecture Series. Endometrial Cancer April 30, 2003.

17.  Chamberlain DH, DePasquale SE. Co-Directors of First Annual University of Tennessee College of Medicine, Erlanger Cancer Symposium. Featuring Gynecologic Malignancies 2003.

18.  DePasquale SE, University of Tennessee College of Medicine, Chattanooga, and Erlanger Health System Third Annual Cancer Symposium. Round table discussion/presentation HRT and Breast Cancer April 2005.

19.  Innes C., DePasquale SE. Cavitational Ultrasonic Surgical Ablation of the Vulva. ACOG Tennessee Section. Nashville Tennessee April 2006.

20.  Pierce C., DePasquale SE, HPV Vaccine Survey of Primary Care Physicians. ACOG Tennessee Section. Nashville Tennessee April 2006.

21.  DePasquale, SE. Can We Cure Cervical Cancer? ACOG Tennessee Section. Nashville Tennessee April 2006.

22.  Mulch A, Brunner B, Sager C, DePasquale SE. A Pilot Study to Evaluate Cavitational Ultrasonic Surgical Ablation in the Treatment of Cervical Intraepithelial Neoplasia. ACOG National Meeting. San Diego, California May 2006.

23.  DePasquale, SE. HPV Vaccination Update: Can We Cure Cervical Cancer? University of Tennessee Medical Grand Rounds. January 2007.

24.  DePasquale, SE. Robotic Surgery, The Next Generation of Laparoscopic Surgery. University of Tennessee Surgical Grand Rounds. April 2007.

25.  DePasquale, SE. Robotic Surgery, The Next Generation of Laparoscopic Surgery. Tennessee Association of Surgical Technologist March 2008.

26.  DePasquale, SE. Robotic Surgery Fad or the Next Generation of Laparoscopic Surgery? ACOG Tennessee Section Chattanooga, Tennessee June 2008.

27.  DePasquale, SE. The Basic Nuts and Bolts of a Robotic Surgery Program. ACOG Tennessee Section Chattanooga Tennessee June 2008

COMMITTEES AND OFFICES HELD:

April 2006 – Present Parkridge Medical Center Surgery Committee

July 2001 – Present Erlanger Health System Cancer Committee

July 2001 – Present Parkridge Medical Center Cancer Committee

April 2002 – Present UTCOM, Chattanooga,

Resident Research Advisory Committee

November 2003 – Present UTCOM, Chattanooga, Department OB/GYN

Research Committee

January 2004 – 2006 Pharmacy & Therapeutics Committee/

Gynecologic Oncology Group

March 2004 – January 2006 American Cancer Society Board of Directors

February 2005 – Present Nicholas’s Heart Foundation Co-Chairman

PEER-REVIEWED JOURNAL ARTICLES:

1.  DePasquale SE, McGuinness T, Husson M, Woodland M, Mangan C. Adenoid Cystic Carcinoma of Bartholin’s Gland: A Review of the Literature and Report of a Patient. Gynecologic Oncology 1996;61:122-125.

2. Woodland M, DePasquale SE, Molinari J, Sagullo C. Laparoscopic Approach to the Interstitial Pregnancy. The Journal of the American Association of Gynecologic Laparoscopists 1996;3:439-441.

3. DePasquale SE, Giordano A, Donnenfeld A. Molecular Genetics of Ovarian Cancer: Review and Clinical Application. Obstetrical & Gynecologic Survey 1998; 53,4: 248-256.

4. Lambert-Messerlian GM, DePasquale SE, Maybruck WM, Steinhoff MM, Gajewski WH. Secretion of Activin A in Recurrent Epithelial Ovarian Cancer. Gynecologic Oncology. 1999;74, 93-97.

5. DePasquale SE, Lambert-Messerlian GM, Quddus M, Campbell I, Steinhoff MM, Gajewski WH, Tantravahi U. Molecular Analysis of Activin A and Inhibin A Subunit Gene Loci in Epithelial Ovarian Cancer. Int. J. Gynecol Cancer 2002 Sep Oct 12(5):

443-7.

6.  DePasquale SE, Lambert-Messerlian GM, Maybruck WM, Steinhoff MM, Gajewski

WH. Preoperative Evaluation of Serum Activin Levels In Ovarian Pathology: Benign

Versus Malignant Disease. Manuscript In Progress.

7. DePasquale SE, Falkenberry S. Fatal Recurrent Ureteroarterial Fistula after Exenteration for Cervical Cancer Gynecologic Oncology 2001 Jul; 82(1): 192-6.

8. Moore R, DePasquale SE, Steinhoff MM, Gajewski W, Steller M, Falkenberry S. Sentinel Node Identification and the Ability to Detect Metastatic Tumor to Inguinal Lymph Nodes In Vulvar Malignancies. Gynecologic Oncology 2003 Jun; 89(3):475-9.

9.  Pearce C, Wolfe L, DePasquale SE, Physician Knowledge and Opinions About Sexually Transmitted Infection and the Human Papilloma Virus Vaccine. A Community Based Survey. Tennessee Medicine Journal of the Tennessee Medical Association 2009 Mar;102(3):33-5, 42.

10.  Wolf L, DePasquale SE, Adair D. Robotic Assisted Laparoscopic Placement of Abdominal Cerclage. J. of Perinatal Medicine. Am J Perinatol. 2008 Nov;25(10):653-5. Epub 2008 Oct 8.

11.  Abdu B, Hobgood D,Stallings S, DePasquale SE. Incidental Finding of Pseudomyxoma Peritonei at Primary Cesarean Section. Am J. Perinatol 2009 Oct;26(9):633-5. Epub 2009 Apr 27.

12.  Carter S, DePasquale S, Stallings S. Robotic-Assisted Laparoscopic Ovarian Cystectomy During Pregnancy. Am J Perinatol Jan 24 2011, 21-24.

13. Naumann RW, Coleman RL, Burger RA, Sausville EA, Kutarska E, Ghamande SA, Gabrail NY, Depasquale SE, Nowara E, Gilbert L, Gersh RH, Teneriello MG, Harb WA, Konstantinopoulos PA, Penson RT, Symanowski JT, Lovejoy CD, Leamon CP, Morgenstern DE, Messmann R. Precedent: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients with Platinum-Resistant Ovarian Cancer.J Clin Oncol. 2013 Dec 10;31(35):4400-6. doi: 10.1200/JCO.2013.49.7685.Epub 2013 Oct 14

14. Widelock T, Elkattah R, Gibbs S, Mashak Z, Mohling S, DePasquale S. Uterine Necrosis associated with Fusobacterium necrophorum Infection. Case Rep Obstet Gynecol. 2015;2015:934913. doi: 10.1155/2015/934913. Epub 2015 Apr 27.

15. Gibbs S, Widelock T, Elkattah R, DePasquale S. Additional uses of a vaginal fornices delineator. Am J Obstet Gynecol. 2015 Jun 19. pii: S0002-9378(15)00629-8. doi: 10.1016/j.ajog.2015.06.029. [Epub ahead of print]

PMID: 26099811

OTHER PUBLICATIONS:

Abstracts:

1.  DePasquale SE, McGuiness T, Multhaupt H, Baldi A, Mangan C, Warhol M, Giordano A. Differential Expression of the Rb2 Tumor Suppressor Gene in Human Epithelial Ovarian Carcinoma. Modern Pathology 1997;10:99A.

2.  DePasquale SE. Prevent Cervical Cancer with Regular Checkups. E-Magazine. Winter 2004 Issue.

3.  Nwadike J, DePasquale SE, Chamberlain DH. A Twist of Fate, Ovarian Torsion Following Radical Hysterectomy. Poster Presentation University of Tennessee College of Medicine, Chattanooga April 2004.

4.  Brunner B, DePasquale SE, Chamberlain DH. A Case Report of Two Ovarian Primary Malignancies of Epithelial and Germ Cell Origin. Poster Presentation University of Tennessee College of Medicine, Chattanooga April 2005.

5.  Pearce C. Wolfe L. DePasquale SE. Physician Knowledge and Opinions About Sexually Transmitted Infection and the Human Papilloma Virus Vaccine. A Community Based Survey. University of Tennessee College of Medicine, Chattanooga Resident Research Week. May 2007.

6.  Wolf L, Adair D, DePasquale SE, Stallings S. Robotic Assisted Laparoscopic Placement of Abdominal Cerclage during Pregnancy. Poster Presentation University of Tennessee College of Medicine Chattanooga. April 2008.

7.  Pierce C, DePasquale SE, Breen JM. Occult Rupture of Mature Cystic Teratoma Mimicking Ovarian Cancer. Poster Presentation University of Tennessee College of Medicine Chattanooga. April 2008.

8.  Abdu B, Hobgood D,Stallings S, DePasquale SE. Incidental Finding of Pseudomyxoma Peritonei at Time of Cesarean Section. Poster Presentation University of Tennessee College of Medicine Chattanooga. April 2008

9.  Messmann R, Depasquale, SE. A randomized phase 2 trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer. ASCO January 2011.

10.  Robotic Assisted Laparoscopic Removal of a Non-Communicating Uterine Horn: A Case Report and Operative Video

Talla Widelock1, MD; Maryam Hadiashar2, MD; Todd Boren3, MD; and Stephen DePasquale3, MD. Poster Presentation University of Tennessee College of Medicine. April 2015.

Clinical Research: Tennessee Gynecologic Oncology Group

Principal Investigator: Below is a sample of the studies I have opened and enrolled to from 2006-present

2006 OVATURE – Covance

2007 OCEANS – AVF4095 – Genentech –

Gynecologic Oncology Group Protocol: Lap II, 0136, 137, 182, 0209, 0212, 0218, 0219

2008 BD Diagnostics – Serum and PAP Study

2008 Precision Therapeutics – CHEMOFX Tissue Study

2009 EC-FV-04 Phase II Endocyte

2011 EC-FV-06 Phase III Endocyte

2011 MORAb Phase II 003-004 Morphotek

2012 BIPI–1199.15 AGO-OVAR12 Boehringer Ingelheim

2015 MorAB Phase III Morphatek

2015 Amgen Observational Study

OTHER SCHOLARLY ACTIVITY

Invited to submit/review questions for the American Board of Obstetrics and Gynecology.

Review manuscripts for the Journal of Surgical Education.

2